Anti TB Therapy Flashcards
- Phases of Drug Treatment in TB
- Overall Objective of anti-TB therapy
2 Phases:
Initial Phase
- Purpose: to decrease bacterial population as rapidly as possible and prevent emergence of drug-resistant bacteria
- Minimum of 2 months duration + until susceptibility results are known
- Isoniazid, Rifampicin, Ethambutol, Pyrazinamide
Continued Phase
- Purpose: prolonged therapy is required to kill dormant organisms in necrotic lesions
- Minimum of 4 months duration but may be longer depending on site of infection and clinical circumstances
- Rifampicin + Isoniazid
Overall Objective of Anti-TB Therapy:
- to achieve a lifetime cure of the disease while preventing drug resistance
Rifampicin
- M.O.A
- Toxicity
- Resistance
M.O.A - inhibits DNA dep RNA poly
Toxicity - hepatotoxicity, induces CYP450, red body fluids
Resistance - develops rapidly due to mutations which reduce drug binding to RNA poly
Isoniazid
- M.O.A
- Toxicity
- Resistance
M.O.A - inhibits the synthesis of mycolic acids
Toxicity - hepatotoxic, inhibits CYP450, neurotoxic (prevented by taking pyridoxine, B6)
Resistance - due to mutations which cause under expression of KatG, which codes for catalase-peroxidase, which activates isoniazid
Pyrazinamide
- M.O.A
- Toxicity
M.O.A - Unknown
Toxicity - hepatotoxic, hyperuricaemia
Ethambutol
- M.O.A
- Toxicity
M.O.A - inhibits arabinose polymerisation, which interferes with cell wall function
Toxicity - reduced visual acuity, red/green color vision loss